MetaCap

Evogene (EVGN) vs Exicure (XCUR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Exicure is the larger company by market cap ($6.5 million vs $6.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EVGN-2.95%XCUR-1.96%
+0%-1%-3%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EVGN versus XCUR key metrics
MetricEVGNXCUR
Share price$0.3985$1.00
Market cap$6.30M$6.55M
1-day change-2.95%-1.96%
EPS (TTM)$-1.55$-1.31
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.49$9.48
52-week low$0.35$0.99
Distance from 52-week high-73.26%-89.45%
Analyst consensusstrong_buy—
Avg. price target upside+439.52%—
Average volume1.50M393.66K
Shares outstanding15.80M6.55M
Employees381
SectorIndustrialsHealth Care
IndustryAgricultural ChemicalsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • The two companies sit in different sectors: Evogene in Industrials and Exicure in Health Care.

About Evogene

EVGN stock →

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications.

Industrials · Agricultural Chemicals · 38 employees

About Exicure

XCUR stock →

Exicure, Inc. does not have significant operations.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

EVGN vs XCUR FAQ

Which is bigger, Evogene or Exicure?

Exicure (XCUR) is larger, with a market capitalization of $6.55M compared with $6.30M for Evogene (EVGN).

Are Evogene and Exicure in the same industry?

No. Evogene is in the Industrials sector, while Exicure is in Health Care.

More comparisons